Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy

Affiliations

¹ Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
² Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
³ Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
⁴ Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
⁵ Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT kevan.herold@yale.edu.

Case Reports

Jing Hughes et al. Diabetes Care. 2015 Apr.

. 2015 Apr;38(4):e55-7.

doi: 10.2337/dc14-2349.

¹ Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
² Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
³ Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.
⁴ Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT.
⁵ Department of Immunobiology, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Section of Endocrinology and Metabolism, Yale University School of Medicine, New Haven, CT kevan.herold@yale.edu.

No abstract available

References

1. Hodi FS, O’Day SJ, McDermott DF, et al. . Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711–723 - PMC - PubMed
1. Brahmer JR, Tykodi SS, Chow LQ, et al. . Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012;366:2455–2465 - PMC - PubMed
1. Robert C, Long GV, Brady B, et al. . Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2015;372:320–330 - PubMed
1. Cernea S, Herold KC. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin Immunol 2010;134:121–129 - PMC - PubMed
1. Velthuis JH, Unger WW, Abreu JR, et al. . Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 2010;59:1721–1730 - PMC - PubMed